Targeted blocking of inflammatory messenger by tablet for the first time

In a clinical phase 2 study, a research team has demonstrated the effectiveness of an IL-23 blocking treatment against psoriasis, which is administered orally

28-Feb-2024 - A promising approach for the treatment of chronic inflammatory diseases involves modern, targeted therapies that inhibit inflammatory messengers, so-called cytokines, or their signaling pathways, and thus block inflammation without interfering with other processes. As a result, they are usually ...